Pharmstandard International S.A.

13F Filings History

Latest 13F report
Q3 2018 - Nov 15, 2018
Value $
$29M
Signature - Title
Eriks Martinovskis - Director
Location
Luxembourg, Luxembourg
Summary
This page shows a list of all the recent 13F filings made by Pharmstandard International S.A.. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Pharmstandard International S.A. reported 6 stock holdings with total value $29M as of Q3 2018. Top holdings included ALNAQ, PTGX, NTGN, JNCE, and PRTO.
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Date Filed
Q3 2018 6 $29M +$5.03M -$54.8K +$4.97M ALNAQ, PTGX, NTGN, JNCE, PRTO 13F-HR 11/15/2018, 03:43 PM
Q2 2018 5 $24.9M $0 -$4.52M -$4.52M ALNAQ, PTGX, JNCE, PRTO, ARGS 13F-HR 8/14/2018, 04:12 PM
Q1 2018 5 $39.6M $0 $0 JNCE, ALNAQ, PTGX, PRTO, ARGS 13F-HR 5/15/2018, 05:11 PM
Q4 2017 5 $42.5M +$10.4M $0 +$10.4M PTGX, ALNAQ, JNCE, PRTO 13F-HR 2/14/2018, 01:41 PM
Q3 2017 4 $33.4M +$1.01M $0 +$1.01M PTGX, JNCE, PRTO, ARGS 13F-HR 11/2/2017, 07:23 PM
Q2 2017 4 $27M $0 $0 PTGX, JNCE, ARGS, PRTO 13F-HR 8/15/2017, 05:24 PM
Q1 2017 4 $35.2M +$14.6M -$16.7K +$14.5M JNCE, PTGX, ARGS, PRTO Restatement 8/16/2017, 08:24 PM
Q4 2016 3 $88.7M $0 $0 ARGS, PTGX, PRTO 13F-HR 2/13/2017, 08:02 PM